BOCH
AEON icon

Blue Owl Capital Holdings’s AEON Biopharma AEON Stock Holding History

Blue Owl Capital Holdings’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.5K Hold
42,353
– – ﹤0.01% 59
2026
Q1 		$41.5K Sell
42,353
-1,042
-2% -$1.17K 0.01% 57
2025
Q4 		$47.7K Buy
43,395
+1,042
+2% +$973 0.01% 57
2025
Q3 		$34.2K Hold
42,353
– – 0.01% 52
2025
Q2 		$32.2K Hold
42,353
– – 0.01% 53
2025
Q1 		$24.6K Buy
42,353
+1
+0% +$7 0.01% 52
2024
Q4 		$1.65M Sell
42,352
-4,054
-9% -$236K 0.38% 32
2024
Q3 		$3.51M Buy
+46,406
New +$4.08M 0.68% 31

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Blue Owl Capital Holdings's AEON Position: Q2 2026 in Review

Blue Owl Capital Holdings held its AEON Biopharma (AEON) position steady in Q2 2026 at 42,353 shares worth $30.5K. The position accounts for ﹤0.01% of the portfolio, ranked #59.

Blue Owl Capital Holdings first reported a position in AEON in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.51M in Q3 2024. 22 funds tracked by Wall St. Rank hold AEON as of Q2 2026.

  • Blue Owl Capital Holdings held 42,353 shares of AEON Biopharma worth $30.5K as of Q2 2026.
  • Blue Owl Capital Holdings left its AEON Biopharma share count unchanged in Q2 2026.
  • AEON Biopharma made up ﹤0.01% of Blue Owl Capital Holdings's portfolio in Q2 2026, its #59 holding.
  • Blue Owl Capital Holdings first reported a position in AEON Biopharma in Q3 2024 and has held it in 8 quarters since.
  • Blue Owl Capital Holdings's AEON Biopharma position peaked at $3.51M in Q3 2024.
  • 22 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2026.

Based on Blue Owl Capital Holdings's 13F filing for Q2 2026, filed 11 Aug 2026.